Name | MEDGARANT, OOO |
---|
INN | 2632095716 |
---|
KPP | 263201001 |
---|
OGRN | 1092632001880 |
---|
OKPO | 62620546 |
---|
Address | 357502, kray Stavropol'skiy, g. Pyatigorsk, ul. Zheleznodorozhnaya, d. D. 125 |
---|
Phone | Contact details |
|
OKVED code | Type | Name of activity type |
---|
46.46 | Core activity | Wholesale of pharmaceutical goods | 47.73 | Additional activity | Retailing drugs in specialized stores (pharmacies) | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | All types of activities | 47.75 | Additional activity | Retailing of cosmetics and personal hygiene products in specialized stores |
Registration date | 07.08.2009 |
---|
Registering department | Inspektsiya Federal'noy nalogovoy sluzhby po g. Pyatigorsku Stavropol'skogo kraya |
---|
|
MEDGARANT, OOO (Stavropol Krai; INN 2632095716) was registered on 7 Aug 2009. The company's authorized capital as of July 1, 2012 was 10000 rub. Type of ownership of MEDGARANT, OOO - Limited liability companies. Form of ownership of MEDGARANT, OOO - Private property. Principal activities of MEDGARANT, OOO: wholesale of pharmaceutical goods (46.46), retailing drugs in specialized stores (pharmacies) (47.73), retailing products used for medical purposes, orthopedic goods in specialized stores (47.74). |
Economic indicators2022
Net profit (RAS) of MEDGARANT, OOO grew over 2022 by 3.23% to 14.48 million RUB from 14.03 million RUB over 2021, the company informed. Revenue increased in the accounting period 1.61 times to 133.53 million RUB from 83.14 million RUB over 2021. 2021
Net profit (RAS) of MEDGARANT, OOO grew over 2021 by 9.43% to 14.03 million RUB from 12.82 million RUB over 2020, the company informed. Revenue decreased in the accounting period by 43.51% to 83.14 million RUB from 147.19 million RUB in 2020. 2020
Net profit (RAS) of MEDGARANT, OOO grew over 2020 by 34.35% to 12.82 million RUB from 9.54 million RUB over 2019, the company informed. Revenue increased in the accounting period by 36.80% to 147.19 million RUB from 107.59 million RUB over 2019. 2019
Net profit (RAS) of MEDGARANT, OOO grew over 2019 by 19.85% to 9.54 million RUB from 7.96 million RUB over 2018, the company informed. Revenue increased in the accounting period 1.95 times to 107.59 million RUB from 55.28 million RUB over 2018. 2018
Net profit (RAS) of MEDGARANT, OOO grew over 2018 by 2.06% to 7.96 million RUB from 7.80 million RUB over 2017, the company informed. Revenue increased in the accounting period by 7.59% to 55.28 million RUB from 51.38 million RUB over 2017; cost of goods sold grew by 15.96% to 46.52 million RUB from 40.12 million RUB; sales profit fell by 22.19% to 8.76 million RUB from 11.26 million RUB. 2017
Net profit (RAS) of MEDGARANT, OOO dropped in 2017 by 8.92% to 7.80 million RUB from 8.56 million RUB over the same period in 2016, the company informed. Revenue increased in the accounting period by 28.88% to 51.38 million RUB from 39.87 million RUB over 2016; cost of goods sold grew by 29.78% to 40.12 million RUB from 30.91 million RUB; sales profit went up by 25.78% to 11.26 million RUB from 8.96 million RUB. 2016
Net profit (RAS) of MEDGARANT, OOO grew over 2016 by 6.55% to 8.56 million RUB from 8.04 million RUB over 2015, the company informed. Revenue increased in the accounting period by 20.92% to 39.87 million RUB from 32.97 million RUB over 2015; cost of goods sold grew by 30.99% to 30.91 million RUB from 23.60 million RUB; sales profit fell by 4.44% to 8.96 million RUB from 9.37 million RUB. 2014
Net profit (RAS) of MEDGARANT, OOO grew over 2014 by 17.84% to 2.13 million RUB from 1.81 million RUB over 2013, the company informed. Revenue increased in the accounting period by 23.38% to 19.07 million RUB from 15.46 million RUB over 2013; cost of goods sold decreased by 0.51% to 11.70 million RUB from 11.76 million RUB; sales profit went up by 30.00% to 2.63 million RUB from 2.02 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|